Epothilone ZK-219477 in Treating Patients With Recurrent Glioblastoma
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as epothilone ZK-219477, work in different ways
to stop the growth of tumor cells, either by killing the cells or by stopping them from
dividing.
PURPOSE: This phase II trial is studying how well epothilone ZK-219477 works in treating
patients with recurrent glioblastoma.
Phase:
Phase 2
Details
Lead Sponsor:
European Organisation for Research and Treatment of Cancer - EORTC